FT. LEE, N.J.--(BUSINESS WIRE)--In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories (NYSE: FRX) and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
